Comparison of photosensitizers in saline and liposomes for tumor photodynamic therapy and skin phototoxicity.

A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity.

New photosensitizers for photodynamic therapy.

Porphyrin dimers as photosensitizers in photodynamic therapy.

Research and development of photodynamic therapy photosensitizers in China.

Research and development of photodynamic therapy photosensitizers in China.

New photodynamic therapy with next-generation photosensitizers.

Physicochemical properties of potential porphyrin photosensitizers for photodynamic therapy.

Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy.

Synthesis and characterization of novel purpurinimides as photosensitizers for photodynamic therapy.

Amphiphilic zinc phthalocyanine photosensitizers: synthesis, photophysicochemical properties and in vitro studies for photodynamic therapy.

Fullerene Nanoparticle Photosensitizers.

Synthesis, characterization, and biological evaluation of new Ru(II) polypyridyl photosensitizers for photodynamic therapy.

Gold nanorod enhanced two-photon excitation fluorescence of photosensitizers for two-photon imaging and photodynamic therapy.

Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: Synthesis and photophysical properties.

Photodynamic Therapy for Non-Melanoma Skin Cancers.

Effect of photosensitizers in chemical and biological processes: the MTO mechanism in photodynamic therapy.

Preclinical examination of first and second generation photosensitizers used in photodynamic therapy.

Photodynamic Therapy and Non-Melanoma Skin Cancer.

In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy.

Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo.

Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a.

Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.

Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer.

Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Suggest Documents

A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity.

New photosensitizers for photodynamic therapy.

Porphyrin dimers as photosensitizers in photodynamic therapy.

Research and development of photodynamic therapy photosensitizers in China.

Research and development of photodynamic therapy photosensitizers in China.

New photodynamic therapy with next-generation photosensitizers.

Physicochemical properties of potential porphyrin photosensitizers for photodynamic therapy.

Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy.

Synthesis and characterization of novel purpurinimides as photosensitizers for photodynamic therapy.

Amphiphilic zinc phthalocyanine photosensitizers: synthesis, photophysicochemical properties and in vitro studies for photodynamic therapy.

Fullerene Nanoparticle Photosensitizers.

Synthesis, characterization, and biological evaluation of new Ru(II) polypyridyl photosensitizers for photodynamic therapy.

Gold nanorod enhanced two-photon excitation fluorescence of photosensitizers for two-photon imaging and photodynamic therapy.

Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: Synthesis and photophysical properties.

Photodynamic Therapy for Non-Melanoma Skin Cancers.

Effect of photosensitizers in chemical and biological processes: the MTO mechanism in photodynamic therapy.

Preclinical examination of first and second generation photosensitizers used in photodynamic therapy.

Photodynamic Therapy and Non-Melanoma Skin Cancer.

In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy.

Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo.

Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a.

Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.

Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer.

Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Comparison of photosensitizers in saline and liposomes for tumor photodynamic therapy and skin phototoxicity.

Recommend Documents

Follow Us